baber/WOPTO huggingface dataset:
Patent AU-2019203146-A1 (AU)
Title: A system, computing device and application server for voting
Inventor: BUTLER KYLE
IPC: G06Q90/00
Filed: 2019-05-03
Abstract: A system for verifying a voter identity in an electronic voting system, the system including: a data network, a server in communication with the data network, the server including a database, the database being adapted for storing voter identification data representing identification information of at least one voter, wherein the server is further adapted to send, via the data network, key data, the key data representing information for authenticating the voter computing device, a verifier computing device in communication with the data network and in operable communication with the server, and a voter computing device in communication with the data network and in operable communication with the server; wherein, in use the voter computing device is adapted to send, via the data network to the server, unlock data in relation to a unique device identifier data, the voter computing device is further adapted to receive voter identification data, the voter identification data representing identification information of the voter, the voter identification data including unique device identifier data, the unique device identifier data representing the unique device identifier of the voter computing device, the voter computing device is adapted to send, via the data network, the voter identification data to the server, the server is adapted to store the voter identification data in the database, and on verification of the identification information of the voter and the voter computing device, the verifier computing device is adapted to send, via the data network, successful verification data to the server, the successful verification data representing the voter having been successfully verified. WO 2014/066956 PCT/AU2013/001277 *1/11 -Display DeviceJ 1 RAM] t ROMJ Processor 1000 101 AV interface Storage 10itraeNetwork. device ntraeInterface 170 190< PC Network. '180 160 HID k orage Image 130 medium - capture 1060 reader device Storage 12media Figure 1
Patent AU-2019203650-A1 (AU)
Title: A patient interface
Inventor: HOPKINS CAROLINE GERALDINE
IPC: A61M16/06
Filed: 2019-05-24
Abstract: - 72 This invention relates to a patient interface, such as a nasal cannula, comprising a body to be positioned upon a user (preferably such as a user's face), the body including at least one (and preferably a pair of) nasal prong(s), the or each nasal prong including a lumen capable of being fluidly connected thereto for fluid communication with a supply of breathable gas, the or each nasal prong to be in a configuration either inserted into, or to direct a flow of gas toward, a nare or the nares of the user's nose, wherein the body includes at least one element responsive to force(s) or movement(s), or both, experienced by at least a first region of the patient interface. Figure to accompany abstract: Figure 7C WO 2015/057083 PCT/NZ2014/000217 Fla 7Bl
Patent AU-2019207706-A1 (AU)
Title: Communicating mobility events in an IMS network environment
Inventor: RAHMAN MUHAMMAD TAWHIDUR
IPC: H04W8/02
Filed: 2019-01-09
Abstract: The disclosed system provides a facility to communicate to an Internet Protocol Multimedia Subsystem network an indication of mobility events occurring in a telecommunications access network. A mobile device connects to a first base station and registers on an IMS network. A component in the IMS network stores the first identifier. The TAS creates or modifies a call detail record to indicate that the mobile phone is connected to the base station. After a handover occurs from the first base station to a second base station, the mobile device transmits to the IMS network a second identifier that identifies the second base station. The mobile device transmits the identifier of the second base station to the TAS within the IMS network via an XCAP PUT or POST request. After receiving the second identifier, the TAS stores the received second identifier and modifies a CDR to reflect the received second identifier.
Patent AU-2019208196-A1 (AU)
Title: Wnt compositions and methods for purification
Inventor: DHAMDHERE GIRIJA
IPC: A61P19/08
Filed: 2019-07-24
Abstract: Abstract Disclosed herein are methods, processes, compositions, and kits for generating bone graft materials for use at a site of bone defect that utilizes a composition which contains liposomal Wnt polypeptide, such as liposomal Wnt3a polypeptide, liposomal Wnt5a polypeptide, or liposomal WntlOb polypeptide. Also disclosed herein are methods, processes, compositions, and kits for enhancing mammalian bone marrow cells that utilizes a composition which contains liposomal Wnt polypeptide, such as liposomal Wnt3a polypeptide, liposomal Wnt5a polypeptide, or liposomal Wnt1Ob polypeptide.
Patent AU-2019218989-A1 (AU)
Title: Chimeric antigen receptors targeting the tumor microenvironment
Inventor: MAUS MARCELA V
IPC: C07K16/30
Filed: 2019-02-12
Abstract: The invention provides methods and compositions for use in treating cancer, which advantageously may be achieved by targeting of a tumor microenvironment. The invention provides chimeric antigen receptors (CARs) that target a tumor microenvironment. In one aspect, the invention features an immune cell engineered to express: (a) a chimeric antigen receptor (CAR) polypeptide including an extracellular domain including a first antigenbinding domain that binds to a first antigen and a second antigen-binding domain that binds to a second antigen; and (b) a bispecific T cell engager (BiTE), wherein the BiTE binds to a target antigen and a T cell antigen. In another aspect, the invention features a pharmaceutical composition including the immune cell. In another aspect, the invention features a method of treating a cancer in a subject in need thereof, the method comprising administering the immune cell.
Patent AU-2019226122-A1 (AU)
Title: Roll Cage and Locking and Unlocking methods thereof
Inventor: CHUNRONG XIA
IPC: B62B3/00
Filed: 2019-09-02
Abstract: The present invention discloses a fully closeable roll cage (1), at least comprising: a first side panel (2); a second side panel (3); a first door (4) openably mounted on one of the first side panel (2) and the second side panel (3); and a second door (5) openably mounted on one of the first side panel (2) and the second side panel (3); wherein the fully closeable roll cage (1) is configured such that it can be locked fully by means of an interlocking mechanism by only locking the first door (1). Also disclosed are a method for locking the fully closeable roll cage (1) and a method for unlocking the fully closeable roll cage (1). According to the present invention, the fully closeable roll cage (1) can be locked by using only one lock, which is very simple and easy for operators to operate and thus will save operating time. Fig.1 11642603_1 (GHMatters) P111903.AU 19 -4 95 6 -21 Tr4U4 24- \17 8 Fig.1
Patent AU-2019227845-A1 (AU)
Title: A method and system for determining the location of artefacts and/or inclusions in a gemstone, mineral, or sample thereof
Inventor: FLEDDERMANN ROLAND
IPC: G01N21/88
Filed: 2019-03-04
Abstract: A method and system for determining a location of artefacts and/or inclusions in a gemstone, mineral or sample thereof, the method comprising the steps of: surface mapping a gemstone, mineral or sample thereof to determine surface geometry associated with at least a portion of a surface of the gemstone, mineral or sample thereof; sub-surface mapping the gemstone, mineral or sample thereof using an optical beam that is directed at the surface along an optical beam path, wherein the optical beam is generated by an optical source using an optical tomography process; determining a surface normal at the surface at an intersection point between the optical beam path and the determined surface geometry; determining relative positioning between the surface normal and the optical beam path; and determining the location of artefacts and/or inclusions in the gemstone, mineral or sample thereof based on the sub-surface mapping step and the determined relative positioning.
Patent AU-2019257436-A1 (AU)
Title: Speed planning device for a vehicle
Inventor: WALLSTEDT PHILIP
IPC: B60W40/076
Filed: 2019-10-30
Abstract: 18-0933-73254 -0 c0 a> (D FL L. 2 ) E a) > Abstract SPEED PLANNING DEVICE FOR A VEHICLE A speed planning device is disclosed. The speed planning device may perform a method including obtaining elevation information associated with a route for a vehicle; identifying a section of the route based on the elevation information, wherein the section is associated with a change in elevation; determining subsections of the section; determining respective slopes of the subsections and respective lengths of the subsections; obtaining information identifying a mass associated with the vehicle; generating a speed plan for the vehicle to traverse the section, wherein the speed plan indicates one or more speeds at which the vehicle is to correspondingly traverse the subsections based on the respective slopes of the subsections, the respective lengths of the subsections, and the mass associated with the vehicle; and providing the speed plan to permit the vehicle to be controlled to traverse the section according to the one or more speeds of the speed plan. 18-0933-73254 c"Jo C)C. C:)) * C''4 * 0 0)0 -C 'a U) C*4 c CO 4- (D _ t 0) N U0 Ucu a) C4 0 (0 cci a)l o 0o
Patent AU-2019264591-A1 (AU)
Title: RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA)
Inventor: BARTZ STEVE
IPC: C12N15/11
Filed: 2019-11-13
Abstract: RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS B VIRUS (HBV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) Abstract The present invention relates to compounds, compositions, and methods for the study, diagnosis, and treatment of traits, diseases and conditions that respond to the modulation of HBV gene expression and/or activity, and/or modulate a HBV gene expression pathway. Specifically, the invention relates to double-stranded nucleic acid molecules including small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules that are capable of mediating or that mediate RNA interference (RNAi) against HBV gene expression. AH26(23789354 1):RTK
Patent AU-2019264639-A1 (AU)
Title: Pipe repair
Inventor: BRITTON JULIAN
IPC: F16L55/44
Filed: 2019-11-15
Abstract: Abstract A method for repairing a partially collapsed pipe. The method comprises fitting a mesh stent around the outside of an actuation assembly of a pipe repair apparatus, wherein the actuation assembly comprises a plurality of arms. The method further comprises positioning the pipe repair apparatus within a portion of the pipe, at least a part of the portion of the pipe being partially collapsed; causing actuation, of at least one of the arms in the plurality of arms, between a retracted configuration in which the at least one arm exerts substantially no force against an interior surface of the pipe, and an extended configuration in which the at least one arm extends outwards to exert a force against the mesh stent and the interior surface of the pipe, such that the partially collapsed part of the pipe changes from a partially collapsed form towards a non-collapsed form. The method further comprises removing the pipe repair apparatus from the pipe and leaving the mesh stent in the portion of the pipe.
Patent AU-2019272010-A1 (AU)
Title: Earth-moving machinery collision threat filtering
Inventor: GRAVES NOLAN
IPC: B60W30/08
Filed: 2019-11-28
Abstract: Abstract EARTH-MOVING MACHINERY COLLISION THREAT FILTERING A method for collision threat filtering is disclosed. The method may include determining trajectory information associated with a plurality of machines. The method may include identifying, based on the trajectory information, one or more potential collisions among the plurality of machines, the one or more potential collisions including a potential collision between a first machine, of the plurality of machines, and a second machine of the plurality of machines. The method may include determining whether to filter the potential collision between the first machine and the second machine. Whether the potential collision is filtered may be determined based on a set of filtering parameters and machine information associated with at least one of the first machine or the second machine. The method may include selectively performing a collision prevention action, associated with the potential collision, based on whether the potential collision is to be filtered. 1/9 18-1045-73252 -C Q 0 cC 0 n co 0 C>U a) 0-co i Z a)) cu a) o 40 a CG) Dc a) n a) 00 (D~ >'
Patent AU-2019288371-A1 (AU)
Title: Methods of manufacturing amino acid compositions
Inventor: HANLON THOMAS
IPC: A61K38/07
Filed: 2019-06-19
Abstract: This disclosure provides methods of manufacturing large-scale blended preparations comprising one or more amino acids wherein the preparations have certain properties.
Patent AU-2019295790-A1 (AU)
Title: Inhibiting creb binding protein (CBP)
Inventor: SCHILLER SHAWN E R
IPC: A61P35/00
Filed: 2019-06-28
Abstract: The present disclosure is directed to inhibitors of the CBP/p300 family of bromodomains. The compounds can be useful in the treatment of disease or disorders associated with the inhibition of the CBP/p300 family of bromodomains. For instance, the disclosure is concerned with compounds and compositions for inhibition of the CBP/p300 family of bromodomains, methods of treating, preventing, or ameliorating diseases or disorders associated with the inhibition of CBP/p300 family of bromodomains, and methods of synthesis of these compounds.
Patent AU-2019304032-A1 (AU)
Title: Methods of treating HFpEF employing dapagliflozin and compositions comprising the same
Inventor: LANGKILDE ANNA MARIA
IPC: A61P9/00
Filed: 2019-07-18
Abstract: Methods for treating and/or preventing HFpEF and/or at least one disease, disorder, and/or condition associated therewith in patients by the use of dapagliflozin and compositions comprising the same are disclosed.
Patent AU-2019324134-A1 (AU)
Title: Antagonistic anti-tumor necrosis factor receptor superfamily polypeptides
Inventor: FAUSTMAN DENISE L
IPC: C07K16/28
Filed: 2019-08-20
Abstract: Described are antagonistic TNFR2 polypeptides, such as antibodies and antigen-binding fragments thereof, and the use of these polypeptides to inhibit the proliferation of regulatory T cells (T- regs) and/or myeloid-derived suppressor cells (MDSCs), to expand T effector cell populations or function, and to reduce the proliferation of, or directly kill, tumor cells, such as tumor cells that express TNFR2 antigen. The polypeptides, such as antibodies and antigen-binding fragments thereof, are TNFR2 antagonists, such as dominant TNFR2 antagonists. The polypeptides can be used to suppress the T-reg- or MDSC-mediated deactivation of tumor reactive T lymphocytes, expand populations of tumor-reactive cytotoxic T cells, and/or to directly kill TNFR2+ tumor cells. The antagonistic TNFR2 polypeptides described herein can be used to treat a wide variety of cancers and infectious diseases.
Patent AU-2019336819-A1 (AU)
Title: Feedstock solution flow concentration system
Inventor: HOTTA DAISUKE
IPC: B01D69/10
Filed: 2019-09-03
Abstract: A feedstock solution flow concentration system, which has a first step for causing counterflow or parallel flow of a feedstock solution flow a, which contains a solute and a solvent b, and a draw solution flow d via a forward osmosis membrane o and transferring the solvent b in the feedstock solution flow a to the draw solution flow d to obtain a concentrated feedstock solution flow c, which is the feedstock solution flow that has been concentrated, and a diluted draw solution flow e, which is the draw solution flow that has been diluted, wherein: the draw solution flow d contains an inducing substance Xm, a common solute Xn, and a solvent b; the solvents b in the feedstock solution flow a and the draw solution flow d both contain water; the common solute Xn is a solute that the feedstock solution flow a and the draw solution flow d have in common and is the same solute as at least one kind of solute contained in the feedstock solution flow a; and the concentration of the common solute Xn in the draw solution flow d is 1% to less than 100% of the concentration of the common solute Xn in the feedstock solution flow a.
Patent AU-2019362595-A1 (AU)
Title: Crystalline form II of 2'-O-fucosyllactose, process for its preparation, nutritional, cosmetic or pharmaceutical formulation containing the same
Inventor: VIERTELHAUS MARTIN
IPC: C07H3/06
Filed: 2019-10-17
Abstract: Crystalline form II of 2'-O-fucosyl lactose having an X-ray powder diffraction pattern comprising three reflections at 2θ angles (13.65 ± 0.20)°, (16.98 ± 0.20)° and (18.32 ± 0.20)°, determined at a temperature of 25 °C with Cu-Kα
Patent AU-2019385311-A1 (AU)
Title: Interactive electronic assignment of services to providers based on custom criteria
Inventor: KUMAR RAJIV
IPC: G06Q30/00
Filed: 2019-11-14
Abstract: A service provider matching system can receive service provider data and preferences, customer data and preferences, and a customer request for service and determine matching scores for one or more matching service providers. Based on a threshold value, the service providers with a matching score above the threshold can be presented to a customer for selection. Upon selection by a customer, an assisted interaction can take place between the customer and one or more selected service providers to agree to particular terms related to a requested service, book a service appointment, and track the progress until completion.
Patent AU-2019393724-A1 (AU)
Title: Providing most recent application views from user devices
Inventor: WALKER JAMES ROBERT
IPC: G06F9/451
Filed: 2019-11-19
Abstract: A last task view is captured for an application executing on a user device, in response to detecting that the user has stopped using the application. The user device may be a mobile device, and the application executing on the user device may be a native application. The last task view may be an image of the contents of a user interface displayed on the user device by the application when the user stopped using the application, and is transmitted from the user device to a server computer for storage in a repository storing views of applications most recently used by the user. A viewer application executing on the server computer may then display the views of applications most recently used by the user to the user on a user device other than the user device on which the last task view was captured.
Patent AU-2019396990-A1 (AU)
Title: Lactobacillus fermentum WiKim0102 having anticancer activity and composition comprising same as effective component
Inventor: CHOI HAK JONG
IPC: A23K10/16
Filed: 2019-12-04
Abstract: The present invention relates to a novel Lactobacillus fermentum WiKim0102 (Accession No. KCCM12356P) isolated from kimchi, and to a composition comprising same as an effective component. The Lactobacillus fermentum WiKim0102 according to the present invention exhibits excellent anti-cancer activities in existing animal models and animal models with human tumor cells transplanted therein, and thus can be beneficially used as a composition for use in treatment, prevention, or alleviation of cancer in humans or animals.
Patent AU-2019426889-A1 (AU)
Title: Knuckle joint assembly for medical device support system
Inventor: MOSS BERNARD JOHN
IPC: F16D49/08
Filed: 2019-12-04
Abstract: Knuckle joint assembly for a medical device support system. The knuckle joint assembly includes a cartridge assembly that includes a cartridge housing and a rotary bearing. The cartridge housing includes a bore having a central axis and a bearing mount in the bore. The rotary bearing is press fitted in the bearing mount and configured to receive axially therethrough a spindle to rotatably support the spindle about the central axis. The knuckle joint assembly includes a retaining clip and a retaining pin. The retaining clip is selectively movable to disengage and engage a groove in a spindle to respectively support or release the spindle along a central axis. The retaining pin is movable between a first position to allow movement of the retaining clip between positions but prevent removal of the retaining clip, and a second position to block movement of the retaining clip from the engaged position.
Patent WO-2021068027-A1 (WO)
Title: Modelmaking system for designing buildings.
Inventor: SHAW MICHAEL
IPC: G09B25/04
Filed: 2020-09-24
Abstract: A parts library apparatus of predesigned freestanding three dimensional box like forms representing modest room sized units, each complete with a floor, walls and a roof of a particular shape and pitch and further categorised as either room units with full height walls and lower pitched roofs, or loft units with higher pitched roofs and some short wall or no wall sides, together with three types of unit assembly defined as non-core, core, or a combination of both, so that by selecting a kit of parts containing at least one type of unit from the parts library, a user can assemble them in accordance with at least one of the three types of unit assembly to form at least one model building and building design which can be easily reconfigured to produce many alternative design options.
Patent AU-2020201620-A1 (AU)
Title: Compositions and combinations for the treatment of angiogenesis diseases and disorders
Inventor: SREDNI BENJAMIN
IPC: A61P17/06
Filed: 2020-03-04
Abstract: The present invention relates to compositions, combinations and methods for treating, reducing, ameliorating, alleviating, or inhibiting the progression of, angiogenesis diseases and disorders in a patient in need thereof (such as for example AMD), utilising Te containing compounds.
Patent AU-2020203923-A1 (AU)
Title: Systems and methods for cards and devices operable to communicate via light pulses and touch sensitive displays
Inventor: MULLEN JEFFREY D
IPC: G06K5/00
Filed: 2020-06-12
Abstract: A card is provided with a touch transmitter operable to electrically communicate touch 
signals to a touch-sensitive screen such as a capacitive touch sensitive screen. In doing 
so, for example, a card may directly communicate with a mobile telephonic device or 
5 portable computer (e.g., a tablet computer). A card is provided with a light sensor 
operable to receive information via light emitted from a display screen or another source 
of light. Accordingly, a mobile telephonic device or portable computer (e.g., tablet 
computer) may communicate information to a card via light pulses. Information 
communicated via light may include, for example, points balances, credit balances, 
0 debit balances, transaction history, software updates, coupons, promotions, 
advertisements or any other type of information.